Autres langues Marksans Pharma Limited

Actions

MARKSANS

INE750C01026

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:52 13/05/2024			Varia. 5j.	Varia. 1 janv.
156 ^INR	-2,04%		-6,00%	-3,17%

14/02	Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024
13/02	Marksans Pharma Limited annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA	18/04
Marksans Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02
Marksans Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Marksans Pharma Arm Gets UK Regulator's Approval to Market Cyanocobalamin Tablets	06/11
Marksans Pharma Undergoes Successful Inspection from German Health Authorities	01/11
CARE Affirms A+ Rating on Marksans Pharma's Long-term Bank Financing; Outlook Stable	12/10/23
Marksans Pharma Gets US FDA Nod for Esomeprazole Magnesium Delayed-Release Capsules	03/10/23
Marksans Pharma Limited Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg	03/10/23
Marksans Pharma Limited Approves Payment of Dividend	28/08/23
Marksans Pharma Limited Appoints Shailaja Vardhan as an Independent Director	28/08/23
Marksans Pharma Gets US FDA's Final Approval for Generic Cough Medicine	22/08/23
Marksans Pharma Ltd. Receives USFDA Approval for Guaifenesin Extended-Release Tablets	22/08/23
Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Marksans Pharma Limited Recommends Payment of Dividend for the Financial Year 2022-23	08/08/23
Marksans Pharma's Goa Plant Gets Two Observations from US FDA	07/08/23
Marksans Pharma Gets US FDA Nod for Pain Relief Drug	12/07/23
Marksans Pharma Limited Announces That It Has Received Final Approval from the Us Food and Drug Administration for Its Abbreviated New Drug Application for Acetaminophen and Ibuprofen Tablets, 250 Mg/125 Mg	12/07/23
Marksans Pharma Limited Approves Declaration of Dividend for the Financial Year 2022-23, Payable on or After 12 June, 2023	30/05/23
Marksans Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23
Marksans Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Marksans Pharma Limited

Actions

MARKSANS

INE750C01026

Autres langues

Filtres